Literature DB >> 15194782

Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.

Wendy Fitzgerald1, Andrew W Sylwester, Jean-Charles Grivel, Jeffrey D Lifson, Leonid B Margolis.   

Abstract

Ex vivo human immunodeficiency virus type 1 (HIV-1) infection of human lymphoid tissue recapitulates some aspects of in vivo HIV-1 infection, including a severe depletion of CD4(+) T cells and suppression of humoral immune responses to recall antigens or to polyclonal stimuli. These effects are induced by infection with X4 HIV-1 variants, whereas infection with R5 variants results in only mild depletion of CD4(+) T cells and no suppression of immune responses. To study the mechanisms of suppression of immune responses in this ex vivo system, we used aldrithiol-2 (AT-2)-inactivated virions that have functional envelope glycoproteins but are not infectious and do not deplete CD4(+) T cells in human lymphoid tissues ex vivo. Nevertheless, AT-2-inactivated X4 (but not R5) HIV-1 virions, even with only a brief exposure, inhibit antibody responses in human lymphoid tissue ex vivo, similarly to infectious virus. This phenomenon is mediated by soluble immunosuppressive factor(s) secreted by tissue exposed to virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194782      PMCID: PMC421649          DOI: 10.1128/JVI.78.13.7061-7068.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  MHC-I-restricted presentation of HIV-1 virion antigens without viral replication.

Authors:  F Buseyne; S Le Gall; C Boccaccio; J P Abastado; J D Lifson; L O Arthur; Y Rivière; J M Heard; O Schwartz
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

2.  Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses.

Authors:  D W Notermans; J J de Jong; J Goudsmit; M Bakker; M T Roos; L Nijholt; J Cremers; J A Hellings; S A Danner; A de Ronde
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

3.  Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

Authors:  M T Esser; J W Bess; K Suryanarayana; E Chertova; D Marti; M Carrington; L O Arthur; J D Lifson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses.

Authors:  Erin Mehlhop; Loreley A Villamide; Ines Frank; Agegnehu Gettie; Christine Santisteban; Davorka Messmer; Ralf Ignatius; Jeffrey D Lifson; Melissa Pope
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

5.  CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.

Authors:  J C Grivel; L B Margolis
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

6.  HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.

Authors:  S Moir; A Malaspina; K M Ogwaro; E T Donoghue; C W Hallahan; L A Ehler; S Liu; J Adelsberger; R Lapointe; P Hwu; M Baseler; J M Orenstein; T W Chun; J A Mican; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Authors:  Susan Moir; Kisani M Ogwaro; Angela Malaspina; Joshua Vasquez; Eileen T Donoghue; Claire W Hallahan; Shuying Liu; Linda A Ehler; Marie A Planta; Shyamasundaran Kottilil; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

8.  Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo.

Authors:  Jean-Charles Grivel; Fabio Santoro; Silvia Chen; Giovanni Fagá; Mauro S Malnati; Yoshinori Ito; Leonid Margolis; Paolo Lusso
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Presentation of exogenous whole inactivated simian immunodeficiency virus by mature dendritic cells induces CD4+ and CD8+ T-cell responses.

Authors:  Ines Frank; John J Santos; Erin Mehlhop; Loreley Villamide-Herrera; Christine Santisteban; Agegnehu Gettie; Ralf Ignatius; Jeffrey D Lifson; Melissa Pope
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09-01       Impact factor: 3.731

10.  Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge.

Authors:  J D Lifson; M Piatak; J L Rossio; J Bess; E Chertova; D Schneider; R Kiser; V Coalter; B Poore; R Imming; R C Desrosiers; L E Henderson; L O Arthur
Journal:  J Med Primatol       Date:  2002-08       Impact factor: 0.667

View more
  5 in total

1.  Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus.

Authors:  Eric G Meissner; Liguo Zhang; S Jiang; Lishan Su
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

2.  HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

Authors:  Adriano Boasso; Jean-Philippe Herbeuval; Andrew W Hardy; Stephanie A Anderson; Matthew J Dolan; Dietmar Fuchs; Gene M Shearer
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

3.  Immune suppression of human lymphoid tissues and cells in rotating suspension culture and onboard the International Space Station.

Authors:  Wendy Fitzgerald; Silvia Chen; Carl Walz; Joshua Zimmerberg; Leonid Margolis; Jean-Charles Grivel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-12       Impact factor: 2.416

4.  Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

Authors:  Angélique Biancotto; Jean-Charles Grivel; Sarah J Iglehart; Christophe Vanpouille; Andrea Lisco; Scott F Sieg; Robert Debernardo; Kristen Garate; Benigno Rodriguez; Leonid B Margolis; Michael M Lederman
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

5.  Mechanisms of residual immune activation in HIV-1-infected human lymphoid tissue ex vivo.

Authors:  Vincenzo Mercurio; Wendy Fitzgerald; Christophe Vanpouille; Ivan Molodtsov; Leonid Margolis
Journal:  AIDS       Date:  2021-07-01       Impact factor: 4.632

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.